Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants

Signal Transduct Target Ther. 2022 Feb 8;7(1):42. doi: 10.1038/s41392-022-00910-6.

Abstract

SARS-CoV-2 variants have evolved a variety of critical mutations, leading to antigenicity changes and immune escape. The recent emerging SARS-CoV-2 Omicron variant attracted global attention due to its significant resistance to current antibody therapies and vaccines. Here, we profiled the mutations of Omicron and other various circulating SARS-CoV-2 variants in parallel by computational interface analysis and in vitro experimental assays. We identified critical mutations that lead to antigenicity changes and diminished neutralization efficiency of a panel of 14 antibodies due to diverse molecular mechanisms influencing the antigen-antibody interaction. Our study identified that Omicron exhibited extraordinary potency in immune escape compared to the other variants of concern, and explores the application of computational interface analysis in SARS-CoV-2 mutation surveillance and demonstrates its potential for the early identification of concerning variants, providing preliminary guidance for neutralizing antibody therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing / immunology*
  • Antibodies, Viral / immunology*
  • Antigens, Viral* / genetics
  • Antigens, Viral* / immunology
  • COVID-19* / genetics
  • COVID-19* / immunology
  • HEK293 Cells
  • Humans
  • Immune Evasion*
  • SARS-CoV-2* / genetics
  • SARS-CoV-2* / immunology

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antigens, Viral

Supplementary concepts

  • SARS-CoV-2 variants